Sovarix Bioscience LLP
About Sovarix Bioscience LLP
Data last updated:
Sovarix Bioscience LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 July 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAJ-9434. Its GSTIN is 24ADKFS4214M1ZV (Gujarat).
The LLP has a total obligation of contribution of ₹2 Lakh. It is led by designated partners Manjulaben Dahyalal Modi and Meet Dahyabhai Modi.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2022, the LLP reported a revenue of ₹93.14 Lakh, a growth of 51% compared to the previous year. For the same year it recorded a net loss of ₹2.69 Lakh (net margin -2.9%) and EBITDA of ₹92,570 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years.
Court records list 1 case involving the LLP, including 1 filed by the LLP; 1 case is pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No. 4 & 5 2nd Floor Malhar Complex Near Malhar Flat Sola Railway Overbridg, E, Ahmedabad, Gujarat, India – 380060
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Sovarix Bioscience LLP FY 2025 filings available
Sovarix Bioscience LLP reported revenue of ₹93.14 Lakh (up 51% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Sovarix Bioscience LLP
Revenue has grown at a compounded annual rate (CAGR) of 27% over three years, including 51% growth in the latest year. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sovarix Bioscience LLP
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | -₹2.69 Lakh | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sovarix Bioscience LLP
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | -2.9% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Sovarix Bioscience are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Sovarix Bioscience LLP
Sovarix Bioscience has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manjulaben Dahyalal Modi Also directs: Tripada Bio-Tech Private Limited | Designated Partner | 11 Jul 2017 | 9 Years 3 Months | Current |
| Meet Dahyabhai Modi | Designated Partner | 11 Jul 2017 | 9 Years 3 Months | Current |
Ownership and Shareholding of Sovarix Bioscience LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sovarix Bioscience LLP
Sovarix Bioscience LLP does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Sovarix Bioscience LLP
Sovarix Bioscience LLP has 1 court case on record: 1 filed by Sovarix Bioscience. All case is pending. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (TMSUIT) | Filed by the company against Westcoast Pharmaceutical Works Limited | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Sovarix Bioscience LLP
Employment history and EPFO contributions of people linked to Sovarix Bioscience.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sovarix Bioscience LLP
Sovarix Bioscience LLP has 4 designated partner changes on record since 2017: 3 appointments and 1 cessation. The latest: Dahyalal Punjiram Modi ceased to be Designated Partner on 16 Jul 2024.
Credit Ratings, Litigation & Regulatory Alerts for Sovarix Bioscience LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sovarix Bioscience LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sovarix Bioscience LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sovarix Bioscience LLP
Sovarix Bioscience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24ADKFS4214M1ZV | Gujarat | Active | 15 Aug 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sovarix Bioscience LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sovarix Bioscience LLP
Sovarix Bioscience is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 11 July 2017 (9+ years old) and is registered under LLPIN AAJ-9434.
Sovarix Bioscience reported revenue of ₹93.14 Lakh for FY 2022 (up 51% YoY).
Sovarix Bioscience has 2 current designated partners:
- Manjulaben Dahyalal Modi - Designated Partner
- Meet Dahyabhai Modi - Designated Partner
Sovarix Bioscience reported a net loss of ₹2.69 Lakh (net margin -2.9%) and EBITDA of ₹92,570 (EBITDA margin 1%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sovarix Bioscience is 27% over three years. In the latest year (FY 2022) revenue rose 51%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sovarix Bioscience is 24ADKFS4214M1ZV, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Sovarix Bioscience is AAJ-9434. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Sovarix Bioscience has 1 court case on record: 1 filed by the LLP. 1 is pending.
Sovarix Bioscience was incorporated on 11 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Dahyalal Punjiram Modi ceased to be Designated Partner on 16 Jul 2024. Dahyalal Punjiram Modi was appointed as Designated Partner on 11 Jul 2017. Manjulaben Dahyalal Modi was appointed as Designated Partner on 11 Jul 2017. Sovarix Bioscience has 4 designated partner changes on record in total.